Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adly Yacoub

Showing results (41-50 of 80) with videos related to

Pageof 8
Sort By:
Molecular Cancer Therapeutics|May 6, 2010
17-allylamino-17-demethoxygeldanamycin and MEK1/2 inhibitors kill GI tumor cells via Ca2+-dependent suppression of GRP78/BiP and induction of ceramide and reactive oxygen speciesTeneille Walker, Clint Mitchell, Margaret A Park, et al.
Molecular Cancer Therapeutics|September 16, 2008
Mitogen-activated protein kinase kinase 1/2 inhibitors and 17-allylamino-17-demethoxygeldanamycin synergize to kill human gastrointestinal tumor cells in vitro via suppression of c-FLIP-s levels and activation of CD95Margaret A Park, Guo Zhang, Clint Mitchell, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 9, 2004
mda-7/IL-24: exploiting cancer's Achilles' heelIrina V Lebedeva, Moira Sauane, Rahul V Gopalkrishnan, et al.
Molecular Cancer Therapeutics|February 20, 2007
17-Allylamino-17-demethoxygeldanamycin enhances the lethality of deoxycholic acid in primary rodent hepatocytes and established cell linesClint Mitchell, Margaret A Park, Guo Zhang, et al.
Molecular Cancer Therapeutics|March 19, 2008
Transient exposure of carcinoma cells to RAS/MEK inhibitors and UCN-01 causes cell death in vitro and in vivoHossein Hamed, William Hawkins, Clint Mitchell, et al.
Autophagy|February 27, 2008
PERK-dependent regulation of MDA-7/IL-24-induced autophagy in primary human glioma cellsMargaret A Park, Adly Yacoub, Devanand Sarkar, et al.
Molecular Pharmacology|June 21, 2007
Low-dose BBR3610 toxicity in colon cancer cells is p53-independent and enhanced by inhibition of epidermal growth factor receptor (ERBB1)-phosphatidyl inositol 3 kinase signalingClint Mitchell, Peyman Kabolizadeh, John Ryan, et al.
Molecular Pharmacology|April 20, 2006
OSU-03012 promotes caspase-independent but PERK-, cathepsin B-, BID-, and AIF-dependent killing of transformed cellsAdly Yacoub, Margaret A Park, David Hanna, et al.
Cancer Biology & Therapy|January 29, 2010
OSU-03012 enhances Ad.7-induced GBM cell killing via ER stress and autophagy and by decreasing expression of mitochondrial protective proteinsHossein A Hamed, Adly Yacoub, Margaret A Park, et al.
International Journal of Radiation Oncology, Biology, Physics|September 17, 2008
RLIP76 in defense of radiation poisoningJyotsana Singhal, Sharad S Singhal, Sushma Yadav, et al.
Pageof 8

Showing results (41-50 of 80) with videos related to

Sort By:
Pageof 8
Molecular Cancer Therapeutics|May 6, 2010
17-allylamino-17-demethoxygeldanamycin and MEK1/2 inhibitors kill GI tumor cells via Ca2+-dependent suppression of GRP78/BiP and induction of ceramide and reactive oxygen speciesTeneille Walker, Clint Mitchell, Margaret A Park, et al.
Molecular Cancer Therapeutics|September 16, 2008
Mitogen-activated protein kinase kinase 1/2 inhibitors and 17-allylamino-17-demethoxygeldanamycin synergize to kill human gastrointestinal tumor cells in vitro via suppression of c-FLIP-s levels and activation of CD95Margaret A Park, Guo Zhang, Clint Mitchell, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 9, 2004
mda-7/IL-24: exploiting cancer's Achilles' heelIrina V Lebedeva, Moira Sauane, Rahul V Gopalkrishnan, et al.
Molecular Cancer Therapeutics|February 20, 2007
17-Allylamino-17-demethoxygeldanamycin enhances the lethality of deoxycholic acid in primary rodent hepatocytes and established cell linesClint Mitchell, Margaret A Park, Guo Zhang, et al.
Molecular Cancer Therapeutics|March 19, 2008
Transient exposure of carcinoma cells to RAS/MEK inhibitors and UCN-01 causes cell death in vitro and in vivoHossein Hamed, William Hawkins, Clint Mitchell, et al.
Autophagy|February 27, 2008
PERK-dependent regulation of MDA-7/IL-24-induced autophagy in primary human glioma cellsMargaret A Park, Adly Yacoub, Devanand Sarkar, et al.
Molecular Pharmacology|June 21, 2007
Low-dose BBR3610 toxicity in colon cancer cells is p53-independent and enhanced by inhibition of epidermal growth factor receptor (ERBB1)-phosphatidyl inositol 3 kinase signalingClint Mitchell, Peyman Kabolizadeh, John Ryan, et al.
Molecular Pharmacology|April 20, 2006
OSU-03012 promotes caspase-independent but PERK-, cathepsin B-, BID-, and AIF-dependent killing of transformed cellsAdly Yacoub, Margaret A Park, David Hanna, et al.
Cancer Biology & Therapy|January 29, 2010
OSU-03012 enhances Ad.7-induced GBM cell killing via ER stress and autophagy and by decreasing expression of mitochondrial protective proteinsHossein A Hamed, Adly Yacoub, Margaret A Park, et al.
International Journal of Radiation Oncology, Biology, Physics|September 17, 2008
RLIP76 in defense of radiation poisoningJyotsana Singhal, Sharad S Singhal, Sushma Yadav, et al.
Pageof 8